Physician profile
Huck A Holz
NPI 1821069394
$7,148.73
in general payments reported to CMS, 2019-2025
7 companies · $4,706 in 2025
The $4,706 reported for 2025 was more than what 93% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $447 · 2021: $125 · 2022: $159 · 2023: $1,049 · 2024: $663 · 2025: $4,706.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,500 · Food and Beverage: $1,893 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,500.00 |
| Food and Beverage | $1,892.83 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $4,688.78 | 2024-2025 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Alcon Vision LLC | $1,297.99 | 2019-2025 | Clareon, Wavelight Refractive Suite, Argos |
| Carl Zeiss Meditec USA, INC. | $503.02 | 2022-2025 | Cirrus Hd-Oct |
| Glaukos Corporation | $284.60 | 2023 | |
| Carl Zeiss Meditec, INC. | $180.79 | 2019 | |
| Sun Pharmaceutical Industries INC. | $131.79 | 2024 | |
| Harrow Eye, LLC | $61.76 | 2025 | Vevye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Huck Holz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.